The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tislelizumab with anlotinib and chemotherapy for second-line treatment of pancreatic ductal adenocarcinoma: A pilot study early result.
 
Xuyuan Dong
No Relationships to Disclose
 
Yinying Wu
No Relationships to Disclose
 
Yangwei Fan
No Relationships to Disclose
 
Yu Shi
No Relationships to Disclose
 
Meichen Wang
No Relationships to Disclose
 
Danfeng Dong
No Relationships to Disclose
 
Enxiao Li
No Relationships to Disclose